Literature DB >> 11557562

The slow mo mutation reduces pacemaker current and heart rate in adult zebrafish.

K S Warren1, K Baker, M C Fishman.   

Abstract

Genetic studies in zebrafish have focused on embryonic mutations, but many physiological mechanisms continue to mature after embryogenesis. We report here that zebrafish homozygous for the mutation slow mo can be raised to adulthood. In the embryo, the slow mo gene is needed to regulate heart rate, and its mutation causes a reduction in pacemaker current (I(h)) and slowing of heart rate (bradycardia). The homozygous adult slow mo fish continues to manifest bradycardia, without other evident ill effects. Patch-clamp analysis of isolated adult cardiomyocytes reveals that I(h) has chamber-specific properties such that the atrial current density of I(h) is far greater than the ventricular current density of I(h). I(h) is markedly diminished in cardiomyocytes from both chambers of slow mo mutant fish. Thus I(h) continues to be a critical determinant of pacemaker rate even after adult neural and humoral influences have developed. It is clear that zebrafish may be used for genetic dissection of selected physiological mechanisms in the adult.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11557562     DOI: 10.1152/ajpheart.2001.281.4.H1711

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  28 in total

Review 1.  Optical mapping in the developing zebrafish heart.

Authors:  M Khaled Sabeh; Hussein Kekhia; Calum A Macrae
Journal:  Pediatr Cardiol       Date:  2012-03-30       Impact factor: 1.655

Review 2.  Regulation of recombinant and native hyperpolarization-activated cation channels.

Authors:  Samuel G A Frère; Mira Kuisle; Anita Lüthi
Journal:  Mol Neurobiol       Date:  2004-12       Impact factor: 5.590

3.  Isolation and in vitro culture of primary cardiomyocytes from adult zebrafish hearts.

Authors:  Veronika Sander; Guillermo Suñe; Chris Jopling; Cristina Morera; Juan Carlos Izpisua Belmonte
Journal:  Nat Protoc       Date:  2013-03-28       Impact factor: 13.491

Review 4.  HCN-related channelopathies.

Authors:  Mirko Baruscotti; Georgia Bottelli; Raffaella Milanesi; Jacopo C DiFrancesco; Dario DiFrancesco
Journal:  Pflugers Arch       Date:  2010-03-08       Impact factor: 3.657

5.  Effects of seasonal acclimatization on thermal tolerance of inward currents in roach (Rutilus rutilus) cardiac myocytes.

Authors:  Ahmed Badr; Hanna Korajoki; El-Sabry Abu-Amra; Mohamed F El-Sayed; Matti Vornanen
Journal:  J Comp Physiol B       Date:  2017-09-23       Impact factor: 2.200

6.  Optical mapping of the electrical activity of isolated adult zebrafish hearts: acute effects of temperature.

Authors:  Eric Lin; Amanda Ribeiro; Weiguang Ding; Leif Hove-Madsen; Marinko V Sarunic; Mirza Faisal Beg; Glen F Tibbits
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-03-26       Impact factor: 3.619

7.  Sinoatrial tissue of crucian carp heart has only negative contractile responses to autonomic agonists.

Authors:  Matti Vornanen; Mervi Hälinen; Jaakko Haverinen
Journal:  BMC Physiol       Date:  2010-06-11

8.  Zebrafish heart as a model to study the integrative autonomic control of pacemaker function.

Authors:  Matthew R Stoyek; T Alexander Quinn; Roger P Croll; Frank M Smith
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-06-24       Impact factor: 4.733

9.  Pacemaker channel dysfunction in a patient with sinus node disease.

Authors:  Eric Schulze-Bahr; Axel Neu; Patrick Friederich; U Benjamin Kaupp; Günter Breithardt; Olaf Pongs; Dirk Isbrandt
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

10.  The zebrafish as a novel animal model to study the molecular mechanisms of mechano-electrical feedback in the heart.

Authors:  Andreas A Werdich; Anna Brzezinski; Darwin Jeyaraj; M Khaled Sabeh; Eckhard Ficker; Xiaoping Wan; Brian M McDermott; Calum A Macrae; David S Rosenbaum
Journal:  Prog Biophys Mol Biol       Date:  2012-07-23       Impact factor: 3.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.